; Animal Drug Compounding Market Size, Industry Share, Analysis, Forecast, 2032

Animal Drug Compounding Market

Animal Drug Compounding Market by Product (CNS Agents, Anti-Infective Agents, Hormones and Substitutes, Anti-Inflammatory Agents, Others), by Animal Type (Companion Animals, Livestock Animals), by Formulation (Injectable Animal Drugs, Oral Animal Drugs, Others) and Region - Global Analysis of Market Size, Share & Trends for 2021-2022 and Forecasts to 2032

Published on: Dec-2022
Report Code: FG HC 01313
No. of Pages: 170 - 350
Report Format: PDF

[170+ Pages Research Reports] Animal Drug Compounding Market to surpass USD 3.5 billion by 2032 from USD 1.6 billion in 2021  at a CAGR of 7.3%  throughout the forecast period 2022-32

Product Overview

Animal Drug Compounding is the act of combining, blending, or modifying substances to produce a treatment specific to the needs of a single animal or a small group of animals. These medications are proved to be extremely important in veterinary medicine. Pharmacy technicians or veterinarians frequently create compounded medications for animals. When the source of the active component is a finished FDA-approved drug instead of than a bulk drug item, the compounding of animal drugs is permitted by the Federal Food, Drug, and Cosmetic Act (FD&C Act). An element used to create a medicine that is then employed as the active ingredient in the completed dosage form of the drug is referred to as a "bulk drug material."

Animal Drug Compounding Market

Get more information - Download free sample

Market Highlights

The Animal Drug Compounding Market is expected to project a notable CAGR of 7.3% in 2032.

Animal Drug Compounding Market to surpass USD 3.5 billion by 2032 from USD 1.6 billion in 2021 at a CAGR of 7.3% in the coming years, i.e., 2022-32. Animal drug compounding is in greater demand due to rising public awareness of the importance of animal health. Moreover, the Animal Drug Compounding Market significantly contributes to bridging the gap between less readily available licensed pharmaceuticals for animal medication and alternative possibilities for veterinary care. Over the forecast period, these factors are anticipated to drive the market.

FIGURE - Market Analysis of Animal Drug Compounding Market


Get more information - Download free sample

Animal Drug Compounding Market: Segments

The CNS Agents segment is expected to grow with a higher CAGR during 2022-32

Animal Drug Compounding Market is categorized on the basis of Product into CNS Agents, Anti-Infective Agents, Hormones and Substitutes, Anti-Inflammatory Agents, and Others. Among all goods and services, the CNS Agents segment held the higher revenue market share in 2021. The most frequent disorders in dogs and cats with CNS inflammation include seizures, impaired limb coordination, behavioral disturbances, and blindness. CNS agents make up the majority of the market since they actively react to the process and regulate nerve activity.

The Companion Animals segment is expected to grow with a higher CAGR during 2022-32

Animal Drug Compounding Market is categorized on the basis of Animal Type into Companion Animals and Livestock Animals. The demand for Animal Drug Compounding Market is being driven by the companion animal category, which held a larger market share in 2021. Sometimes a pet avoids taking the medication since due to its awful taste, which increases a great chance for compounded drug items. Therefore, compounded medications with tailored formulas are delightfully consumed by animals. Companion animals are therefore anticipated to create a significant demand for compounded medications over the projection period.

FIGURE - Market Analysis of Global Animal Drug Compounding


Get more information - Download free sample

Market Dynamics

Growth Drivers :Market Players are focusing on Maintaining a Full Line of Chemicals and Supplies and Quality Assurance

To assist veterinary compounding, businesses in the Animal Drug Compounding Market are working harder to keep their full line of chemicals and supplies in stock. The market's manufacturers collaborate closely with the providers of the APIs, flavors, bases, and formulations that the veterinary compounding industry needs. To increase their trust in the market, manufacturers are concentrating on quality control and adherence to strict standards. In addition to dogs and cats, businesses are expanding their compounding capabilities for horses, birds, and other unusual aquatic and avian animals.

Growing Focus of Pet Owners on Sufficient Medical Care of Different Companion Animals

Veterinarians are increasingly looking outside the commercial availability of FDA-approved drugs due to the growing concern of pet owners on providing companion animals and non-food aquaculture animals with sufficient medical care. Another important aspect that has boosted income generation for market participants is the demand for high-quality compounded formulas for small-animal veterinarians. Compound veterinary medicines are subject to regulatory scrutiny that is rapidly expanding, which supports the market's ongoing demand for innovation. The Animal Drug Compounding Market is significantly driven by these elements.

Restraint: No Assurance from the FDA for the Safety of Compounding Drug Formulations

The safety of medicine formulations made from scratch is not guaranteed by the FDA. They claim that animal-compound medication compositions could, in some cases, seriously impair animal health. This is caused by a number of things, including mistakes in the compounding of drugs, an imbalance in the amount of active substances, physical and chemical instability, drug contamination, and a shortage of bioavailability in the animal to be medicated. Lack of any regulatory standards to identify the exact required strength of compounded medications as described on the prescription label has hampered animal care in various ways.

Recent Developments
  • The official purchase agreement between Wedgewood Pharmacy and Partners Group was accomplished in December 2020. This made New Harbor Capital become the company's majority shareholders.
  • In March 2021, Osceola Capital and seasoned entrepreneur Jacob Beckel announced the formation of Revelation Pharma Corp. to investigate partnerships and investments in the pharmacy compounding market.
  • According to Animal Medicines Australia, Australia spent more than US$ 2.6 billion on animal health services in 2019.

Animal Drug Compounding Market Key Players
  • Wedgewood Pharmacy

Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis

  • Medisca Inc.
  • Smith Caldwell Drug Store
  • Miller's Pharmacy
  • Sixth Avenue Medical Pharmacy
  • Dougherty's Pharmacy
  • Triangle Compounding Pharmacy Inc.
  • Chiron Compounding Pharmacy
  • MEDS Canadian
  • Aurora Compounding
  • Pace Pharmacy
  • Smith’s Pharmacy
  • Amber Compounding Pharmacy
  • Victoria Compounding Pharmacy
  • Pratt’s Compounding Pharmacy
  • Other Prominent Players

Animal Drug Compounding Market: Regions

Animal Drug Compounding Market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. The Animal Drug Compounding Market was dominated by North America, followed by Europe and Asia Pacific. The region's Animal Drug Compounding Market is anticipated to expand due to the high rate of pet ownership and rising veterinary care spending.

In 2019, Europe held a substantial portion of the global market. Animal Drug Compounding Market growth in the area is anticipated to be fueled by an increase in the prevalence of veterinary diseases in European nations and a rise in the use of antibiotic pharmaceuticals for the treatment of veterinary diseases.


Get more information - Download free sample

Impact of Covid-19 on Animal Drug Compounding Market

The COVID-19 outbreak had a quick and uneven impact on the veterinary pharmaceutical sector. Veterinarian procedures were somewhat hampered by the implementation of lockdown in certain areas. For instance, the American Veterinary Medical Association estimated that in April 2020, the epidemic caused the cancellation of almost 60% of global veterinary practices, and that figure fell by 30% in July 2020. As a result, the COVID-19 impact is anticipated to restrain the development of the global Animal Drug Compounded Market.

Animal Drug Compounding Market is further segmented by region into:
  • North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United States and Canada
  • Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil, and Rest of Latin America
  • Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey, and Rest of Europe
  • Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia, and Rest of APAC
  • Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa, and Rest of MENA

Animal Drug Compounding Market report also contains analysis on:

Animal Drug Compounding Market Segments:

  • By Product
    • CNS Agents
    • Anti-Infective Agents
    • Hormones and Substitutes
    • Anti-Inflammatory Agents
    • Others
  • By Animal Type 
    • Companion Animals
    • Livestock Animals
    • By Formulation
      • Injectable Animal Drugs
      • Oral Animal Drugs
      • Others 
  • Animal Drug Compounding Market Dynamics
  • Animal Drug Compounding Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies Involved in the Market
  • Value Chain of the Market
  • Market Drivers and Restraints  

Animal Drug Compounding Market Report Scope and Segmentation 

REPORT ATTRIBUTE

DETAILS

Market Size Value in 2021

USD 1.6 billion

Revenue Forecast in 2032

USD 3.5 billion

Growth Rate

CAGR of 7.3% from 2022 to 2032

Base Year for Estimation

2021

Quantitative Units

Revenue in USD billion and CAGR from 2022 to 2032

Report Coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments Covered

Product, Animal Type, Formulation, and Region

Regional Scope

North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)

Key Companies Profiled

Wedgewood Pharmacy, Medisca Inc., Smith Caldwell Drug Store, Miller's Pharmacy, Sixth Avenue Medical Pharmacy, Dougherty's Pharmacy, Triangle Compounding Pharmacy Inc., Chiron Compounding Pharmacy, MEDS Canadian, Aurora Compounding, Pace Pharmacy, Smith’s Pharmacy, Amber Compounding Pharmacy, Victoria Compounding Pharmacy, Pratt’s Compounding Pharmacy, and Other Prominent Players.

Frequently Asked Questions (FAQ):

The Animal Drug Compounding Market size was estimated at USD 1.6 billion in 2021 and is expected to reach USD 3.5 billion in 2032.

Animal Drug Compounding is the act of combining, blending, or modifying substances to produce a treatment specific to the needs of a single animal or a small group of animals. These medications are proved to be extremely important in veterinary medicine.

The CNS Agents and Companion Animals segments accounted for the larger share of the Animal Drug Compounding Market.

Key players in the Animal Drug Compounding Market are Wedgewood Pharmacy, Medisca Inc., Smith Caldwell Drug Store, Miller's Pharmacy, Sixth Avenue Medical Pharmacy, Dougherty's Pharmacy, Triangle Compounding Pharmacy Inc., Chiron Compounding Pharmacy, MEDS Canadian, Aurora Compounding, Pace Pharmacy, Smith’s Pharmacy, Amber Compounding Pharmacy, Victoria Compounding Pharmacy, Pratt’s Compounding Pharmacy, and Other Prominent Players.

The main drivers of the Animal Drug Compounding Market are the increasing awareness for the benefits of veterinary compounding for medication delivery in animals and the rising number of product approvals or launches.

Select License Type

$3199

Report accessible by 1 user only

In case you require a hard copy, there will be an additional charge of $500. Please email us at info@fatposglobal.com with your request

Call us

Research Assistance

US : +1 (716) 218-3733
UK : +44 (208) 1235555



Select License Type

$3199

Report accessible by 1 user only

Sample Request

Client Testimonials

FATPOS CLIENT Appriciation DURING THE PROJECT

Clients